Antisense Therapeutics Limited’s (ANP) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Antisense Therapeutics Limited is a Sell.

Antisense Therapeutics Limited’s (ANP) 20-Day exponential moving average is 0.06, while Antisense Therapeutics Limited’s (ANP) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited’s (ANP) 50-Day exponential moving average is 0.06, while Antisense Therapeutics Limited’s (ANP) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited (ANP) Pivot Points

Apr 27, 2024, 11:01 PM

Classic

0.06

Fibonacci

0.06

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Antisense Therapeutics Limited (ANP) Moving Averages

Apr 27, 2024, 11:01 PM

MA5

0.06Buy

MA10

0.06Buy

MA20

0.06Buy

MA50

0.06Buy

MA100

0.06Buy

0.06Sell

MA200

0.07Sell

Antisense Therapeutics Limited’s (ANP) 10-Day exponential moving average is 0.06, while Antisense Therapeutics Limited’s (ANP) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited’s (ANP) 100-Day exponential moving average is 0.06, while Antisense Therapeutics Limited’s (ANP) share price is <AU$0.1, making it a Sell.

Antisense Therapeutics Limited’s (ANP) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (ANP) 50-day simple moving average is 0.06, creating a Buy signal.

Antisense Therapeutics Limited’s (ANP) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (ANP) 100-day simple moving average is 0.06, creating a Buy signal.

Antisense Therapeutics Limited’s (ANP) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (ANP) 200-day simple moving average is 0.07, creating a Sell signal.

Antisense Therapeutics Limited (ANP) Technical Indicators

Apr 27, 2024, 11:01 PM

RSI (14)

58.44

Neutral

STOCH (9,6)

87.50

Sell

STOCHRSI (14)

87.50

Sell

MACD (12,26)

>-0.01

Sell

ADX (14)

21.96

Neutral

Williams %R

0.00

CCI (14)

156.95

Sell

ATR (14)

<0.01

Ultimate Oscillator

54.91

Neutral

ROC

8.93

Buy

Antisense Therapeutics Limited’s (ANP) Relative Strength Index (RSI) is 58.44, creating a Neutral signal.

Antisense Therapeutics Limited’s (ANP) Trend Strength Indicator (ADX) is 21.96, creating a Neutral signal.

Antisense Therapeutics Limited’s (ANP) Commodity Channel Index (CCI) is 156.95, creating a Sell signal.

Antisense Therapeutics Limited’s (ANP) Price Rate of Change (ROC) is 8.93, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is ANP a Buy, Hold, or Sell?

Based on ANP’s technical indicators, ANP is a Buy.

What is ANP’s RSI (14)?

ANP’s RSI (14) is 58.44, which suggests ANP is a Neutral.

What is ANP’s MACD?

ANP’s MACD is >-0.01, which suggests ANP is a Sell.

What is ANP’s 5-day moving average?

ANP’s 5-day moving average is 0.06, which suggests ANP is a Buy.

What is ANP’s 20-day moving average?

ANP 20-day moving average is 0.06, which suggests ANP is a Buy.

What is ANP’s 50-day moving average?

ANP’s 50-day moving average is 0.06, which suggests ANP is a Buy.

What is ANP’s 200-day moving average?

ANP’s 200-day moving average is 0.07, which suggests ANP is a Sell.

What is ANP’s Williams % R (14)?

Currently, no data Available

What is ANP’s CCI (14)?

ANP’s CCI (14) is 156.95, which suggests ANP is a Sell.

What is the share price of Antisense Therapeutics Limited?

Antisense Therapeutics Limited's share price is 0.06AU$.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing